Merck KGaA (MRK) Target Price Issued at €108.00 by Kepler Capital Markets

Merck KGaA (MRK) Target Price Issued at €108.00 by Kepler Capital Markets

Merck KGaA (FRA:MRK) received a €108.00 ($125.58) price target from equities research analysts at Kepler Capital Markets in a research report issued to clients and investors on Thursday. The brokerage currently has a “buy” rating on the healthcare company’s stock. Kepler Capital Markets’ price target would indicate a potential upside of 10.61% from the company’s current price.

Several other equities research analysts have also issued reports on the stock. Credit Suisse Group set a €110.00 ($127.91) price target on shares of Merck KGaA and gave the company a “buy” rating in a report on Thursday. Oddo Bhf set a €100.00 ($116.28) target price on shares of Merck KGaA and gave the stock a “neutral” rating in a report on Wednesday. Nord/LB set a €80.00 ($93.02) target price on shares of Merck KGaA and gave the stock a “sell” rating in a report on Wednesday. Warburg Research set a €103.00 ($119.77) target price on shares of Merck KGaA and gave the stock a “neutral” rating in a report on Wednesday. Finally, Goldman Sachs Group set a €95.00 ($110.47) target price on shares of Merck KGaA and gave the stock a “neutral” rating in a report on Wednesday. Two equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and seven have given a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus price target of €98.00 ($113.95).

Shares of Merck KGaA stock opened at €97.64 ($113.53) on Thursday. Merck KGaA has a 52-week low of €76.60 ($89.07) and a 52-week high of €115.00 ($133.72).

Merck KGaA Company Profile

MERCK Kommanditgesellschaft auf Aktien, a science and technology company, operates in the healthcare, life science, and performance materials sectors worldwide. The company offers prescription medicines to treat infertility, growth hormone deficiencies, type 2 diabetes, cardiovascular and thyroid diseases, multiple sclerosis, colorectal cancer, as well as carcinoma of the head and neck; diagnostics and prescription drugs for allergen immunotherapy; and fertility treatments.

See Also: What are different types of coverage ratios?

Related posts

Leave a Comment